Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Belden Inc. filed an amendment to its previous 8-K to provide required audited and pro forma financial statements following its completed acquisition of the RUCKUS reporting segment from Vistance Networks, Inc. The filing includes historical financial data for Ruckus Wireless Networks for 2024, 2025, and the first quarter of 2026 to satisfy SEC reporting requirements for a material acquisition.
Counterparty
Ruckus Wireless Networks (reporting segment of Vistance Networks, Inc.)
John Deere Capital Corporation completed the issuance of $1.8 billion in aggregate principal amount of senior notes across four tranches. The offering includes floating rate notes due 2028 and fixed rate notes with maturities in 2028, 2029, and 2031, issued under the company's automatic shelf registration statement.
Cumberland Pharmaceuticals reported that following its 2026 Annual Meeting, the Board of Directors determined to hold future advisory votes on executive compensation every three years. This decision aligns with the shareholder preference expressed during the advisory vote at the meeting.
Amesite Inc. has prepared presentation materials for use at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026. The presentation highlights the company's AI-powered enterprise solutions for the $1.5 trillion post-acute care market, including its NurseMagic B2B platform and EMR functionality. The company reported international reach across 21 countries and high user ratings for its clinical documentation applications.
Counterparty
H.C. Wainwright 28th Annual Global Investment Conference
The U.S. District Court for the Southern District of California has granted preliminary approval for a settlement of a stockholder derivative action against Acadia Pharmaceuticals and certain of its officers and directors. The settlement resolves claims related to the company's drug pimavanserin (NUPLAZID) and includes the implementation of corporate governance reforms and the payment of plaintiff attorney fees. A final settlement hearing is scheduled for January 13, 2027.
Flexsteel Industries appointed Anand S. Kangala to its Board of Directors as a Class I director and member of the Audit and Ethics Committee, effective September 10, 2026. Mr. Kangala, currently the Chief Digital and Technology Officer of Trex Company, brings expertise in digital transformation, AI, and enterprise technology modernization to the board. He will receive an annual retainer of $75,000 plus quarterly stock grants valued at $26,250.
Toppoint Holdings held its 2026 Annual Meeting where stockholders approved a potential reverse stock split (ratio up to 1-for-900), a reincorporation from Nevada to Delaware, and an increase in authorized common shares from 300 million to 1 billion. Five directors were elected to the board, and the company confirmed its standing committee memberships following the meeting.
Glucotrack $11.6M Debt Financing with certain investors
Glucotrack, Inc. issued senior secured convertible promissory notes in the aggregate principal amount of approximately $11.6 million, which includes a 22% original issue discount. The financing involved $4.5 million in new cash proceeds and the exchange of $4.5 million in existing notes, with the new notes bearing 8% interest and maturing in June 2027.
Sunshine Biopharma announced a reduction in the exercise price of its outstanding Series B Warrants to $1.2046. This adjustment was triggered by recent sales of common stock under the company's existing at-the-market (ATM) offering program. The price remains subject to further potential adjustments based on the terms of the warrants.
Thomas A. Fitzgerald resigned as CFO and Director of TransCode Therapeutics effective September 9, 2026. The company entered into a separation agreement providing for up to $1.25 million in severance payments, accelerated vesting of existing equity, and a new grant of 185,000 stock options. A portion of the cash severance and option vesting is contingent on the company achieving specific funding thresholds of $5 million and $10 million.
Intelligent Bio Solutions Inc. provided an update on its total shares outstanding, which reached 3,316,803 shares as of September 10, 2026. The increase resulted from the exercise of pre-funded warrants for 285,000 shares and the issuance of 4,333 restricted shares under an existing advisory agreement.
Coty Inc. entered into a Transition Agreement with outgoing CFO Laurent Mercier, who will serve as Strategic CEO Advisor through June 30, 2027. Mercier will maintain his €825,000 annual base salary and receive a one-time fixed bonus of €290,000, while assisting with the transition to new CFO Soraya Benchikh.
Greenwave Technology Solutions Capital Raise of $3.75M
Greenwave Technology Solutions closed a private placement of 3,750 shares of Series B Convertible Preferred Stock with five institutional investors. The preferred shares have a stated value of $1,000 per share and are convertible into common stock at an initial conversion price of $5.24 per share. The company filed a Certificate of Designations to authorize the issuance and define the rights of the new preferred securities.
Jeff Mason, the Chief Operating Officer of Flux Power Holdings, Inc., tendered his resignation effective September 25, 2026. In connection with his departure, the company entered into a separation agreement providing Mr. Mason with a $5,000 payment subject to a general release of claims.
Lisa Fan resigned as CEO and Director of Fly-E Group, Inc., effective immediately, with no reported disagreements. The Board appointed Qiang Chen as the new CEO and Jingxia Song as an independent Director and committee member to fill the vacancies.
KULR Technology Group sold its entire remaining holdings of 764 bitcoin through a series of open market transactions for gross proceeds of approximately $58.6 million. The sales were conducted as part of the company's treasury management operations at a weighted average price of $76,633 per BTC.
Dr. Duane Nash resigned from the Board of Directors of Immunic, Inc. on September 10, 2026. Following the resignation, the company reduced the size of its Board from ten to nine members.
Banzai International entered into a securities purchase agreement for a private placement of convertible promissory notes and warrants with an accredited investor. The deal provides for up to $2.5 million in gross proceeds across three tranches, with $1.5 million funded at the initial closing. The notes carry a 30% original issue discount and are convertible into Class A common stock at a fixed price of $2.75 per share.
Brightline Interactive received a staff determination notice from Nasdaq on September 11, 2026, stating that its common stock is subject to delisting for failing to meet the $1.00 minimum bid price requirement. The company failed to regain compliance during the initial 180-day grace period that ended September 9, 2026. Brightline plans to appeal the decision by requesting a hearing before a Nasdaq Hearings Panel, which will stay the suspension of its stock pending a final decision.
SharonAI Holdings entered into a Deed of Release with co-founder Andrew Leece, transitioning him from Chief Operating Officer to Head of Strategic Partnerships. The agreement sets a fixed employment term through March 2027 with an annual base salary of approximately $400,000 USD and a fixed short-term incentive of AUD$422,535. Leece will also retain 151,219 unvested RSUs while forfeiting other previously granted equity awards.
DeFi Development Corp. entered into a sales agreement with R.F. Lafferty & Co., Inc. to establish an at-the-market (ATM) offering program for up to 30,000,000 shares of its Variable Rate Series C Perpetual Preferred Stock (CHAD). The company intends to use any future proceeds for general corporate purposes and the acquisition of Solana (SOL) digital assets, though no shares were sold at the time of filing.
T3 Defense $3M Debt Financing with institutional lender
T3 Defense Inc. executed a $3.0 million Term Note with an institutional lender on September 8, 2026. The note carries an interest rate of 1% per month and is due on December 8, 2026, or upon the completion of certain financing milestones, including a planned $10 million Series B Preferred Stock sale.
Volato Group Signs $500M M&A Deal with Alignment Engine Inc.
Volato Group completed its acquisition of Alignment Engine Inc. (Aligned) on September 11, 2026, in a merger where Aligned securityholders received 95% of the post-closing company's Class A common stock. The transaction was based on an Aligned valuation of $500 million and included a 180-day lock-up period for the newly issued shares. The deal was approved by Volato's board following the receipt of a fairness opinion and did not require stockholder approval.
Visium Technologies implemented a 1-for-1,500 reverse stock split and simultaneously reduced its authorized common stock from 3 billion to 2 million shares. The split uses a lot-by-lot half-up rounding convention where positions of fewer than 750 pre-split shares are extinguished without cash payment. The action was approved by the Board of Directors on September 10, 2026, and filed with the Florida Department of State on September 11, 2026.
Data Storage Insider Clifford Stein Sells $12.2K of Stock
Clifford Stein sold 3,991 shares of Data Storage Corp at $3.05 a share, worth $12.2K in total on Sep 10, 2026. Shares held after the trade: 18,009 (-18.1%).
Warner Bros. Discovery Insider Kenneth W. Lowe Sells $5.65M of Stock
Kenneth W. Lowe sold 200,000 shares of Warner Bros. Discovery, Inc. at $28.23 a share, worth $5.65M in total on Sep 10, 2026. Shares held after the trade: 590,108 (-25.3%).
Halozyme Therapeutics President and CEO Helen Torley Sells $6.44M of Stock
Helen Torley, President and CEO, sold 60,000 shares of Halozyme Therapeutics, Inc. at $107.01 to $108.67 a share (average $107.28) in 7 transactions, worth $6.44M in total between Sep 9, 2026 and Sep 11, 2026. Shares held after the trade: 767,780 (-0.6%).
Alignment Healthcare CEO John E. Kao Sells $7.12M of Stock
John E. Kao, CEO, sold 557,870 shares of Alignment Healthcare, Inc. at $12.68 to $12.96 a share (average $12.77) in 2 transactions, worth $7.12M in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 1,223,473 (-23.9%).
Alignment Healthcare President Dawn Christine Maroney Sells $1.56M of Stock
Dawn Christine Maroney, President, sold 122,707 shares of Alignment Healthcare, Inc. at $12.68 a share, worth $1.56M in total on Sep 11, 2026. Shares held after the trade: 794,606 (-13.4%).
Shankar Musunuri, CEO, sold 525,991 shares of Ocugen, Inc. at $1.12 a share, worth $589K in total on Sep 9, 2026. Shares held after the trade: 1,088,035 (-5.0%).